Celiac Disease: America’s Gluten Problem

American children experience celiac disease at significantly higher rates: 1 in 140 versus 1 in 200 globally, according to NIH’s 2023 pediatric prevalence update. This immune reaction to gluten damages the small intestine. ESPGHAN’s 2023 guidelines confirm the US rate exceeds global averages by 30%. Genetic factors explain some difference, but environmental triggers likely play a role. Improved diagnostic testing has identified many previously missed cases. Strict gluten avoidance remains the only effective treatment despite ongoing research into potential alternatives.